Top stories in dermatology: IMIDs in psoriasis, Dupixent for keloids

December 10, 2019
In a top Healio Dermatology story, preliminary findings from Emma Guttman-Yassky, MD, PhD, demonstrate a novel use of dupilumab for managing chronic…
From OSN Europe

GenSight’s LHON treatment receives French temporary authorization for use

December 10, 2019
A patient at France’s National Eye Hospital of the Quinze-Vingts has been granted temporary authorization for use of Lumevoq, GenSight…

Top stories in infectious disease: HIV progress stalls, Samoa struggles with measles outbreak

December 10, 2019
The CDC’s announcement that reductions in HIV infections in the United States have stalled in recent years was the top story in infectious…
Conference Preview

Southwest Nephrology-Cardio Renal Metabolic Conference focuses on inhibitors, dialysis and cross-specialty care

December 10, 2019
Under the leadership of President Peter McCullough, MD, The Cardio Renal Society of America’s mission is to prevent and manage three…

Focals smart glasses available for online purchase

December 10, 2019
North’s Focals smart glasses can now be purchased online in North America through the new Focals Showroom app. “Since we launched back in…
Meeting News

New insights on diabetes, CVD research from the TIMI Study Group

December 10, 2019
LOS ANGELES — In a presentation at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, speakers highlighted recent…
Feature

‘Worthwhile to consider’: Does the world need a pentavalent flu vaccine?

December 10, 2019
Study findings showed that last season’s influenza vaccine “offered no substantial protection” against H3N2 viruses that moved…
In the Journals

Studies provide insight into 'loneliness epidemic' among older adults

December 10, 2019
A pair of studies published in Psychology and Aging found that among older Americans, claims of a “loneliness epidemic” reflect the…
Meeting News

TEVAR with stent graft system effective at 1 year

December 10, 2019
A thoracic stent graft system was safe and effective at 1 year in patients requiring thoracic endovascular aortic repair, according to new data…

Galectin settles plans for phase 3 trial of NASH-cirrhosis therapy

December 10, 2019
Galectin Therapeutics announced plans for a phase 3 clinical trial of belapectin for patients with nonalcoholic steatohepatitis-related cirrhosis…
Meeting News

COSMIC-HF: Omecamtiv mecarbil may improve diastolic function, pulmonary pressures in HF

December 10, 2019
PHILADELPHIA — Omecamtiv mecarbil, a selective cardiac myosin activator, improved diastolic function and pulmonary pressures without worsening…

Rothman Orthopaedic Institute opioid protocol linked to reduced consumption, refill rate

December 10, 2019
In the past few years, physicians and staff at Rothman Orthopaedic Institute have begun to implement a series of preoperative, intraoperative and…
Meeting NewsVideo

VIDEO: Blinatumomab has potential to become ‘new standard of care’ as post-reinduction therapy for pediatric B-ALL

December 10, 2019
ORLANDO — In this video, Ryan D. Cassaday, MD, attending physician at the Seattle Cancer Care Alliance, associate professor of medicine at the…
Meeting News

Low-cost assay may improve lymphoma diagnostics in lower income countries

December 10, 2019
ORLANDO — A low-cost gene expression assay using FFPE biopsies can classify multiple lymphoma subtypes as well as non-lymphoma diagnoses with…
In the Journals

Walking intervention may increase step counts for patients on dialysis

December 10, 2019
A 3-month intervention using pedometers increased step counts for patients on dialysis, though steps reverted to baseline during the…
Meeting NewsVideo

Polatuzumab vedotin plus obinutuzumab, lenalidomide shows promise in R/R follicular lymphoma

December 10, 2019
ORLANDO — Catherine Diefenbach, MD, director of the clinical lymphoma program and of hematology translational research, Perlmutter Cancer…
FDA News

FDA panel does not recommend approval of vernakalant for AF

December 10, 2019
Citing safety concerns, the Cardiovascular and Renal Drug Advisory Committee of the FDA voted 2-11 against approval of vernakalant for the rapid

Enrollment in ocular graft-versus-host disease trial halfway complete

December 10, 2019
Ocugen has completed 50% of enrollment for a phase 3 trial of OCU300 for the treatment of ocular redness and discomfort in patients with ocular…
Meeting News

Hemophilia B clinically less severe than A, though with similar QOL

December 10, 2019
ORLANDO – Despite clinical evidence that hemophilia B presents with less severity on a clinical level than hemophilia A, patients report…
Meeting NewsVideo

AI tool for NAFLD could ‘make biopsies history’

December 10, 2019
LOS ANGELES — In this video exclusive, Christos S. Mantzoros, MD, PhD, professor of medicine at Harvard Medical School, chief of…